DE2257624A1 - PROCESS FOR PREPARING N- (LAETHYL-2-PYRROLIDYLMETHYL) -2-METHOXY-5AETHYLSULFONYL-BENZAMIDE - Google Patents

PROCESS FOR PREPARING N- (LAETHYL-2-PYRROLIDYLMETHYL) -2-METHOXY-5AETHYLSULFONYL-BENZAMIDE

Info

Publication number
DE2257624A1
DE2257624A1 DE2257624A DE2257624A DE2257624A1 DE 2257624 A1 DE2257624 A1 DE 2257624A1 DE 2257624 A DE2257624 A DE 2257624A DE 2257624 A DE2257624 A DE 2257624A DE 2257624 A1 DE2257624 A1 DE 2257624A1
Authority
DE
Germany
Prior art keywords
methoxy
ethyl
benzamide
pyrrolidylmethyl
laethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2257624A
Other languages
German (de)
Inventor
auf Nichtnennung. MP Antrag
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Renfag SA
Original Assignee
Renfag SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renfag SA filed Critical Renfag SA
Publication of DE2257624A1 publication Critical patent/DE2257624A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/224Phosphorus triamides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Description

2257S242257S24

RENFAG S. A. COLOGNY / SchweizRENFAG S. A. COLOGNY / Switzerland

Verfahren zur Herstellung von N-(l-Aethyl-2-pyrrolidylmethyl)-2-methoxy-5-aethylsulfonyl-benzamidProcess for the preparation of N- (1-ethyl-2-pyrrolidylmethyl) -2-methoxy-5-ethylsulfonyl-benzamide

Die Erfindung betrifft ein Verfahren zur Herstellung von N-(l-Aethyl-2- -pyrrolidylmethyl)-2-methoxy-5-aethylsulfonyl-benzamid und seiner Additionssalze mit für pharmazeutische Zwecke geeigneten Mineral- oder organischen Säuren sowie seiner quaternären Ammoniumsalze durch Umsetzung dieses Benzamids mit einem aliphatischen oder aromatischen Alkyli e r ung s mittel.The invention relates to a process for the preparation of N- (l-ethyl-2- -pyrrolidylmethyl) -2-methoxy-5-aethylsulfonyl-benzamide and its Addition salts with mineral or mineral salts suitable for pharmaceutical purposes organic acids and its quaternary ammonium salts by reacting this benzamide with an aliphatic or aromatic one Alkylating agents.

Das erfindungsgemässe Verfahren ist dadurch gekennzeichnet, dass N-Aethyl-OC-aminomethyl-pyrrolidin mit Phosphoroxychlorid umgesetzt und dann das erhaltene N1, N", NIM-(N-Aethyl-OC-methylpyrrolidin)-phosphoramid kondensiert wird mit 2-Methoxy-5-aethylsulfonyl-benzoesäure.The process according to the invention is characterized in that N-ethyl-OC-aminomethyl-pyrrolidine is reacted with phosphorus oxychloride and the N 1 , N ", N IM - (N-ethyl-OC-methylpyrrolidine) phosphoramide obtained is then condensed with 2-methoxy -5-ethylsulfonylbenzoic acid.

Das auf diese Weise erhaltene Benzamid besitzt wertvolle pharmakologische Eigenschaften, insbesondere als Antiemetikum und Psychotropikum.The benzamide obtained in this way has valuable pharmacological properties Properties, especially as an anti-emetic and psychotropic.

0900/R4U. 12D. 2 - BIl/KW/eb0900 / R4U. 12D. 2 - BIl / KW / eb

309886/1U7309886 / 1U7

Das erfindungsgemässe Verfahren verläuft gemäss nachfolgendein R eaktions schema:The method according to the invention proceeds according to the following Reaction scheme:

O=P-Cl +O = P-Cl +

C2H5 C 2 H 5

O=PO = P

-NH-CH-NH-CH

KJKJ

2 52 5

• 3 HCl• 3 HCl

OHOH

O=PO = P

-NH-CH-NH-CH

(II)(II)

COOHCOOH

H5C2°2S H 5 C 2 ° 2 S

OCH,OCH,

CO-NH-CH-QHCO-NH-CH-QH

OCHOCH

H5C2°2S H 5 C 2 ° 2 S

(I)(I)

(ΠΙ)(ΠΙ)

309886/1147309886/1147

Die vorstehend aufgezeichneten Umsetzungen können in geeigneten Lösungsmitteln durchgeführt werden, wie Bioxaa, Pyridin oder dergleichen, wobei auf Rückflusstemperatur erhitzt wird»The reactions recorded above can be carried out in suitable solvents be carried out, such as Bioxaa, pyridine or the like, heating to reflux temperature »

Die Verwendung von Pyridin als Lösungsmittel bietet den Vorteil, dass das Chlorhydrat des Phosphoramids nicht isoliert zu werden braucht.The use of pyridine as a solvent has the advantage that the chlorohydrate of the phosphoramide need not be isolated.

Die nachfolgenden Beispiele zeigen eine praktische Anwendungsmöglichkeit des erfindungsgemässen Verfahrens.The following examples show a practical application of the method according to the invention.

BEISPIEL 1EXAMPLE 1

N-(I- Ae thyl-2-pyrr olidylraethjjj^-tnethoxy-5-aethylsulfonyl-benzainidchlorhydrat N- (I-ethyl-2-pyrrol idylrae thjjj ^ -tnethoxy-5-ethylsulfonyl-benzainide chlorohydrate

In einem Reaktionsgefäss von einem Liter Inhalt löst man 27g N-Aethyl-GS,-aminomethylpyrrolidin in 56ο ml Pyridin.27 g of N-ethyl-GS, -aminomethylpyrrolidine are dissolved in a one-liter reaction vessel in 56ο ml of pyridine.

Bei Umgebungstemperatur fügt man eine Lösung von 6, Ig Phosphoroxychlorid in 65 ml Pyridin hinzu und rührt die Reaktionsmischung während einer halben Stunde. Darauf wird 15a 6g E-Methosy-5-aethylsulfonylbenzoesäure zugesetzt, worauf die Reaktionsmischung während vier Stunden am Rückfluss gekocht wird.A solution of 6.5 lg phosphorus oxychloride in 65 ml of pyridine is added at ambient temperature and the reaction mixture is stirred for half an hour. This will be added to 15 a 6g E-Methosy-5-aethylsulfonylbenzoesäure, is cooked and the reaction mixture for four hours at reflux.

Nach erfolgter Umsetzung wird das Pyridin im Vakuum verdampft und der Rückstand in 300 ml Wasser und 40 ml Salzsäure (36%) aufgenommen, um etwaige Reste nicht umgesetzter Säure zu entfernen. Die Lösung wird mit einer Lauge alkalisch gemacht und mit Methylenchlorid extrahiert.After the reaction has taken place, the pyridine is evaporated in vacuo and the residue was taken up in 300 ml of water and 40 ml of hydrochloric acid (36%), to remove any residues of unreacted acid. The solution is made alkaline with an alkali and extracted with methylene chloride.

309886/1147309886/1147

Die organische Schicht wird getrocknet, filtriert und im Vakuum eingedampft. Man löst den Rückstand in 20 ml Aceton, und fällt das Chlorhydrat durch Zusatz von Salzsäure aus. Es wird filtriert, mit 10 ml Aethanol gewaschen und im Trockenschrank bei 50 C getrocknet. Man erhält 16g des Chlorhydrates des Be nzamids mit einem Schmelzpunkt von 188-189°C.The organic layer is dried, filtered and evaporated in vacuo. The residue is dissolved in 20 ml of acetone, and the hydrochloric acid is precipitated by adding hydrochloric acid. It is filtered with 10 ml Washed ethanol and dried at 50 ° C. in a drying cabinet. 16 g of the hydrochloride of benzamide with a melting point are obtained from 188-189 ° C.

Dieses Produkt wird zweimal aus Aethanol umkristallisiert und man erhält 10g N-(I- Aethyl-2-pyrrolidylmethyl)-2-methoxy-5-aethyl-sulfonyl benzamidchlorhydrat mit einem Schmelzpunkt von 190-192 C.This product is recrystallized twice from ethanol and 10 g of N- (I-ethyl-2-pyrrolidylmethyl) -2-methoxy-5-ethyl-sulfonyl benzamide chlorohydrate are obtained with a melting point of 190-192 C.

Die Reinheitsbestimmung mit Perchlorsäure ergibt 99» 7 %.The purity determination with perchloric acid gives 99 »7%.

BEISPIEL 2EXAMPLE 2

N', N", N ' " - (N - Ae t hyl -Qc-methylpyrrolidi^-phosphoramidN ', N ", N'" - (N - Ae thyl -Qc-methylpyrrolidi ^ -phosphoramide

In ein Reaktionsgefäss von 250 ml Inhalt bringt man die Lösung von 15, 3g N-Aethyl-Or-aminomethyl-pyrrolidin in 60 ml Toluol. Bei Umgebungstemperatur fügt man hierzu 6,1g Phosphoroxychlorid, gelöst in 40 ml Toluol.The 15.3g solution is placed in a 250 ml reaction vessel N-ethyl-or-aminomethyl-pyrrolidine in 60 ml of toluene. At ambient temperature 6.1 g of phosphorus oxychloride dissolved in 40 ml of toluene are added to this.

Nach Rühren bei Umgebungstemperatur während zwei Stunden wird der gebildete Niederschlag abfiltriert, gewaschen und getrocknet. Man erhält 20, 3g N1, N", Ntll-(N-Aethyl-OC-methylpyrrolidin)-phosphoramid-chlorhydrat mit einem Schmelzpunkt von 106-110 C.After stirring at ambient temperature for two hours, the precipitate formed is filtered off, washed and dried. 20.3 g of N 1 , N ", N tll - (N-ethyl-OC-methylpyrrolidine) phosphoramide chlorohydrate with a melting point of 106-110 ° C. are obtained.

Das auf diese Weise erhaltene Chlorhydrat wird in 350 ml "Wasser gelöstThe hydrochloride obtained in this way is dissolved in 350 ml of "water"

309886/1U7309886 / 1U7

und die Lösung mit einer Lauge alkalisch gemacht. Diese Lösung wird dann mit Chloroform extrahiert. Die organische Schicht wird über Kaliumcarbonat getrocknet und im Vakuum eingedampft. Man erhält 10, 5g N1, N", Nm-(N-Aethyl-Ct-methylpyrrolidin)-phosphoramid.and made the solution alkaline with a lye. This solution is then extracted with chloroform. The organic layer is dried over potassium carbonate and evaporated in vacuo. 10.5 g of N 1 , N ″, N m - (N-ethyl-Ct-methylpyrrolidine) phosphoramide are obtained.

Die Reinheitsbestimmung mit Perchlorsäure ergibt 98,2 %.The purity determination with perchloric acid gives 98.2%.

303888/1U7303888 / 1U7

Claims (2)

PATENTANSPRÜCHEPATENT CLAIMS iy. Verfahren zur Herstellung von N-(l-Aethyl-2-pyrrolidylmethyl)-2-methoxy-5-aethylsulfonyl-benzamid der Formel iy. Process for the preparation of N- (1-ethyl-2-pyrrolidylmethyl) -2-methoxy-5-ethylsulfonyl-benzamide of the formula CO-NH-CHCO-NH-CH OCHOCH und dessen Additions salze mit für pharmazeutische Zwecke geeigneten Mineral- und organischen Säuren sowie seiner quaternären Ammoniumsalze, dadurch gekennzeichnet, dass N-Aethyl-Ot-aminomethyl-pyrrolidin mit Phosphoroxychlorid umgesetzt und das erhaltene Phosphoramid dann mit 2-Methoxy-5-aethylsulfonyl-benzoesäure, gelöst in einem Lösungsmittel, kondensiert wird.and its addition salts with those suitable for pharmaceutical purposes Mineral and organic acids as well as its quaternary ammonium salts, characterized in that N-ethyl-Ot-aminomethyl-pyrrolidine reacted with phosphorus oxychloride and then the phosphoramide obtained with 2-methoxy-5-ethylsulfonylbenzoic acid, dissolved in a solvent, is condensed. 2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, dass als Lösungsmittel Pyridin verwendet wird.2. The method according to claim 1, characterized in that the solvent Pyridine is used. 309886/1U7309886 / 1U7
DE2257624A 1972-07-19 1972-11-24 PROCESS FOR PREPARING N- (LAETHYL-2-PYRROLIDYLMETHYL) -2-METHOXY-5AETHYLSULFONYL-BENZAMIDE Pending DE2257624A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1080272A CH565149A5 (en) 1972-07-19 1972-07-19

Publications (1)

Publication Number Publication Date
DE2257624A1 true DE2257624A1 (en) 1974-02-07

Family

ID=4367011

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2257624A Pending DE2257624A1 (en) 1972-07-19 1972-11-24 PROCESS FOR PREPARING N- (LAETHYL-2-PYRROLIDYLMETHYL) -2-METHOXY-5AETHYLSULFONYL-BENZAMIDE

Country Status (29)

Country Link
JP (2) JPS4935377A (en)
KR (1) KR780000089B1 (en)
AR (1) AR194145A1 (en)
AT (1) AT319932B (en)
AU (1) AU471164B2 (en)
BE (1) BE793871A (en)
BG (1) BG20347A3 (en)
CA (1) CA976974A (en)
CH (1) CH565149A5 (en)
CS (1) CS174865B2 (en)
DD (1) DD102380A5 (en)
DE (1) DE2257624A1 (en)
EG (1) EG11435A (en)
ES (1) ES409348A1 (en)
FR (1) FR2192820B1 (en)
GB (1) GB1394409A (en)
HU (1) HU167514B (en)
IE (1) IE37363B1 (en)
IL (1) IL41522A (en)
LU (1) LU66787A1 (en)
MC (1) MC961A1 (en)
NL (1) NL7215710A (en)
OA (1) OA04313A (en)
PH (1) PH9390A (en)
PL (1) PL82470B1 (en)
RO (1) RO62350A (en)
YU (1) YU36499B (en)
ZA (1) ZA73537B (en)
ZM (1) ZM1773A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1151533B (en) * 1982-03-29 1986-12-24 Ravizza Spa PROCEDURE FOR THE PREPARATION OF P. CHLOROFENOSSIACETIL-PIPERONILPIPERAZINA
WO1991017144A1 (en) * 1990-05-02 1991-11-14 Yoshitomi Pharmaceutical Industries, Ltd. Amide compound, pharmaceutical use thereof and novel 1-substituted pyrrolidinemethyl-amines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4940459B1 (en) * 1970-12-21 1974-11-02

Also Published As

Publication number Publication date
BG20347A3 (en) 1975-11-05
HU167514B (en) 1975-10-28
AU471164B2 (en) 1976-04-08
DD102380A5 (en) 1973-12-12
GB1394409A (en) 1975-05-14
AT319932B (en) 1975-01-10
IL41522A (en) 1977-11-30
AU5151473A (en) 1974-08-01
IE37363L (en) 1974-01-19
JPS4943966A (en) 1974-04-25
YU301572A (en) 1982-02-25
AR194145A1 (en) 1973-06-22
EG11435A (en) 1977-03-31
NL7215710A (en) 1974-01-22
CS174865B2 (en) 1977-04-29
RO62350A (en) 1977-08-15
PH9390A (en) 1975-10-22
IL41522A0 (en) 1973-04-30
CA976974A (en) 1975-10-28
PL82470B1 (en) 1975-10-31
OA04313A (en) 1980-01-15
MC961A1 (en) 1973-12-07
FR2192820A1 (en) 1974-02-15
FR2192820B1 (en) 1976-07-02
IE37363B1 (en) 1977-07-06
KR780000089B1 (en) 1978-04-08
LU66787A1 (en) 1973-03-19
ZA73537B (en) 1973-10-31
ES409348A1 (en) 1975-11-16
CH565149A5 (en) 1975-08-15
BE793871A (en) 1973-05-02
YU36499B (en) 1984-02-29
JPS4935377A (en) 1974-04-01
JPS5532704B2 (en) 1980-08-26
ZM1773A1 (en) 1973-10-22

Similar Documents

Publication Publication Date Title
DE2316377C3 (en) Process for the preparation of 2-phenyl-amino-2-imidazoline derivatives and their salts
DE1240846B (en) Process for the preparation of sulfamides
DE2257624A1 (en) PROCESS FOR PREPARING N- (LAETHYL-2-PYRROLIDYLMETHYL) -2-METHOXY-5AETHYLSULFONYL-BENZAMIDE
DE2256979C3 (en) Process for the preparation of benzenesulfonylureas
DE2256740A1 (en) PROCESS FOR THE PREPARATION OF N (DIAETHYLAMINOETHYL) -2-METHOXY-5-METHYLSULFONYL-BENZAMIDE
DE943050C (en) Process for the production of sulfonic acid esters
DE2230070A1 (en) Process for the preparation of N- (2,4-dihalo-s-triazin-6-yl) ureas
DE2214488C3 (en) Process for the preparation of 1-substituted 4-aminopyiTolin-3-ones (2)
DE1543511C3 (en) Dimethylaminoäthoxy-dihalogenanlllne and process for their preparation
CH630907A5 (en) Process for preparing derivatives of 1-carbamoyluracil.
DE1024954B (en) Process for the preparation of N-disubstituted dithiocarbamic acid esters which contain sulfonic acid groups in the alcohol residue
EP0073871B1 (en) Process for the preparation of n-substituted-n-acylated 2,6-dialkylanilines
DE2034986A1 (en) 4 sulfamoyl m toluidine derivatives
DE2046848C3 (en) Benzodiazepines and processes for their preparation
DE1119263B (en) Process for the production of new sulfonyl urethanes
DE1240873B (en) Process for the preparation of 4-halo-5-sulfamylanthranilic acid hydroxamides
DE2433176A1 (en) 2-Halopyrimidine derivs - prepd. from cyanoimino acetates via N-cyano cyanoimino acetates
DE3500029A1 (en) Anthracycline esters
CH510044A (en) Subst thiadiazoles anticoccidial antibacterial
DE1493854C (en) Benzanilides and process for their preparation
DE1568092C (en) Process for the preparation of new derivatives of 5,10 methano 5H dibenzo square brackets on a, square brackets on cycloheptens
DE1620190C (en) 4- (2-Carbo-alpha-glyceryloxyphenylamino) -8-chloroquinoline, its salts and a process for their preparation
DE2556039C2 (en) Process for the preparation of N, N-dialkylaminophenyl chloroformate hydrochlorides
DE2600665A1 (en) (1,3)-Diaza-(2)-phospha-cyclohexane derivs. - with pharmacodynamic and germicidal activity, prepd. by reacting phosphordiamide cpds. with malonyl chloride derivs.
DEF0011073MA (en)